Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

NCT03991299 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Sponsor Decision.

Conditions

Obese
Diabetes Mellitus, Type 2

Interventions

DRUG: Botox 200 UNT Injection

Sponsor

Vanderbilt University Medical Center